Jiangxi Sanxin MedtecLtd Valuation

Q: What is the Fair Price of 300453 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

300453 (CN¥8.17) is trading above our estimate of [[fair value]] (CN¥4.92)

Is 300453 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300453 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300453 (CN¥8.17) is trading above our estimate of fair value (CN¥4.92)

Significantly Below Fair Value: 300453 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300453?

Key metric: As 300453 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300453. This is calculated by dividing 300453's market cap by their current earnings.
What is 300453's PE Ratio?
PE Ratio	18x
Earnings	CN¥233.14m
Market Cap	CN¥4.17b

300453 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.8x
Enterprise Value/EBITDA	13x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 300453's PE Ratio compare to its peers?

The above table shows the PE ratio for 300453 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	27.7x
603309 Well Lead Medical	18x	20.9%	CN¥3.8b
301580 Aidite (Qinhuangdao) Technology	27x	n/a	CN¥4.3b
688338 Beijing Succeeder Technology	25.6x	21.2%	CN¥2.9b
603205 Jianerkang Medical	40.2x	n/a	CN¥5.6b
300453 Jiangxi Sanxin MedtecLtd	18x	n/a	CN¥4.2b

Price-To-Earnings vs Peers: 300453 is good value based on its Price-To-Earnings Ratio (18x) compared to the peer average (27.7x).

Price to Earnings Ratio vs Industry

How does 300453's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 300453 is good value based on its Price-To-Earnings Ratio (18x) compared to the CN Medical Equipment industry average (34.6x).

Price to Earnings Ratio vs Fair Ratio

What is 300453's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300453 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	18x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 300453's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥6.7b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.65

-6.0%

-35.5%

Chison Medical Technologies

CN¥3.0b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥26.47

4.1%

-41.2%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.71

-1.0%

39.5%